2019 ESC/EAS Guidelines for the management of dyslipidaemias: <i>lipid modification to reduce cardiovascular risk</i>
2019 · European Heart Journal · 8,581 citations
https://doi.org/10.1093/eurheartj/ehz455
L
Loukianos Rallidis
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
20
Papers
22.8K
Citations
12
h-index
12
i10-index
Loukianos Rallidis is an academic researcher from National and Kapodistrian University of Athens. The author has contributed to research in topics: Lipoproteins and Cardiovascular Health & Cancer, Lipids, and Metabolism & Diabetes, Cardiovascular Risks, and Lipoproteins. The author has an h-index of 12, co-authored 17 publications.
Papers by this author
worksEuropean Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
2012 · European Heart Journal · 8,496 citations
https://doi.org/10.1093/eurheartj/ehs092
2019 ESC/EAS guidelines for the management of dyslipidaemias: Lipid modification to reduce cardiovascular risk
2019 · Atherosclerosis · 4,829 citations
https://doi.org/10.1016/j.atherosclerosis.2019.08.014
Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)
2021 · The Lancet · 288 citations
https://doi.org/10.1016/s0140-6736(21)01122-3
Prolonged inhibition of cholesterol synthesis explains the efficacy of atorvastatin
1997 · Journal of Lipid Research · 80 citations
https://doi.org/10.1016/s0022-2275(20)37432-0
Corrigendum to “2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk” [Atherosclerosis 290 (2019) 140–205]
2019 · Atherosclerosis · 15 citations
https://doi.org/10.1016/j.atherosclerosis.2019.12.004
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat